Want to see FR:ALGAE full AI Analyst Report?
Top Page
Fermentalg SA
(ALGAE)
Select Model
Select Model
Rating:46Neutral
Price Target:
€0.51
▲(18.60% Upside)
Action:Reiterated
Date:06/30/26
The score is held down primarily by continued large losses and significant cash burn despite improving revenue and a return to positive gross margin. A relatively conservative leverage position provides some support, but the negative P/E and lack of dividend yield data reinforce the risk profile given the absence of demonstrated profitability.
Positive Factors
Strong Revenue Growth
Sustained multi-year top-line growth demonstrates traction across end markets and supports scale options. A growing revenue base increases the potential to spread fixed bioprocessing costs, improves negotiating leverage with suppliers, and underpins longer-term margin improvement if growth persists.
Negative Factors
Persistent Cash Burn
Ongoing negative operating cash flow and worsening free cash flow create a structural funding requirement. Over months this limits investment flexibility, increases reliance on external capital or dilution, and raises the probability that management must prioritize liquidity over R&D or commercial expansion.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
Sustained multi-year top-line growth demonstrates traction across end markets and supports scale options. A growing revenue base increases the potential to spread fixed bioprocessing costs, improves negotiating leverage with suppliers, and underpins longer-term margin improvement if growth persists.
Read all positive factors
Fermentalg SA (ALGAE) vs. iShares MSCI France ETF (EWQ)
Market Cap
€57.20M
Dividend YieldN/A
Average Volume (3M)224.33K
Price to Earnings (P/E)―
Beta (1Y)0.95
Revenue Growth16.41%
EPS Growth44.74%
CountryFR
Employees58
SectorHealthcare
Sector Strength45
IndustryBiotechnology
Share Statistics
EPS (TTM)-0.09
Shares Outstanding119,939,200
10 Day Avg. Volume242,064
30 Day Avg. Volume224,333
Financial Highlights & Ratios
PEG Ratio0.10
Price to Book (P/B)1.78
Price to Sales (P/S)3.34
P/FCF Ratio-5.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-0.08
Revenue Forecast (FY)€19.55M
Fermentalg SA Business Overview & Revenue Model
Company Description
Fermentalg SA, established in 2009 and headquartered in Libourne, France, is an internationally operating company specializing in the research, manufacturing, and sale of functional ingredients sourced from microalgae. These offerings serve variou...
How the Company Makes Money
null...
Fermentalg SA Financial Statement Overview
Summary
Income Statement
28
Negative
Balance Sheet
54
Neutral
Cash Flow
24
Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 13.38M | 11.50M | 4.06M | 7.65M | 5.65M |
| Gross Profit | 2.29M | 2.50M | 536.00K | -828.00K | -675.00K |
| EBITDA | -6.32M | -9.99M | -10.91M | -7.19M | -8.91M |
| Net Income | -9.44M | -12.88M | -14.15M | -9.87M | -6.85M |
Balance Sheet | |||||
| Total Assets | 36.44M | 51.14M | 50.24M | 57.54M | 60.88M |
| Cash, Cash Equivalents and Short-Term Investments | 6.62M | 20.58M | 11.16M | 15.90M | 26.01M |
| Total Debt | 5.02M | 12.60M | 15.35M | 11.02M | 9.61M |
| Total Liabilities | 11.26M | 18.39M | 19.40M | 15.56M | 13.87M |
| Stockholders Equity | 25.18M | 32.76M | 30.85M | 41.98M | 47.00M |
Cash Flow | |||||
| Free Cash Flow | -8.13M | -2.00M | -11.18M | -13.72M | -12.55M |
| Operating Cash Flow | -6.59M | -531.00K | -8.69M | -8.24M | -7.66M |
| Investing Cash Flow | -1.75M | -1.13M | -1.76M | -7.29M | -4.75M |
| Financing Cash Flow | -5.62M | 11.08M | 5.71M | 5.42M | 26.58M |
Fermentalg SA Technical Analysis
Negative
0.43
Price Trends
0.52
Negative
0.49
Negative
0.48
Positive
Market Momentum
>-0.01
Negative
40.45
Neutral
43.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For FR:ALGAE, the sentiment is Negative. The current price of 0.43 is below the 20-day moving average (MA) of 0.48, below the 50-day MA of 0.52, and below the 200-day MA of 0.48, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 40.45 is Neutral, neither overbought nor oversold. The STOCH value of 43.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for FR:ALGAE.
Fermentalg SA Peers Comparison
UnderperformOutperform
Sector (51)
FR:ALGAE
Fermentalg SA
0.49
-0.03
-5.00%
FR:ALVAL
Valbiotis SA
0.80
0.03
3.61%
FR:ALPAT
Plant Advanced Technologies SA
5.80
-3.50
-37.63%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.